Related by context. All words. (Click for frequent words.) 66 cancer cachexia 66 Cachexia 63 progressive neurodegenerative disorder 62 sarcopenia 61 elevated triglyceride levels 61 debilitating autoimmune 61 mGluR2 NAM 61 non alcoholic steatohepatitis 61 neuronal dysfunction 61 SHPT 60 lysosomal storage diseases 60 lipoatrophy 60 Sarcopenia 60 PAOD 60 muscular dystrophies 60 fibrotic disease 60 diabetic nephropathy 60 neurodegenerative disorder 60 degenerative disorders 59 AA Amyloidosis 59 Cancer cachexia 59 arterial thrombosis 59 lipodystrophy 59 liver fibrosis 59 diabetic kidney 59 cirrhosis liver failure 59 cardiac dysfunction 59 Alzheimer Disease AD 59 AA amyloidosis 59 lupus nephritis 58 insulin resistance syndrome 58 chronic thromboembolic pulmonary 58 cardiac hypertrophy 58 VEGF inhibitors 58 bone metastasis 58 motor neuron degeneration 58 acquired immunodeficiency syndrome 58 systemic fungal infections 58 Cancer Cachexia 58 kidney urologic 58 progressive neurodegenerative 58 MELAS 57 TNFa 57 metabolic abnormalities 57 postoperative ileus 57 nonalcoholic steatohepatitis 57 dopaminergic therapy 57 autoimmune encephalitis 57 AEG# 57 endothelial dysfunction 57 bone marrow suppression 57 hepatic steatosis 57 metabolic parameters 57 Ocrelizumab 57 Angiotensin II 57 neuropathic pain 57 TNFα 57 SGLT2 57 insulin resistance 57 metastatic cancers 57 LHRH agonists 57 Pulmonary hypertension 57 reperfusion injury 57 growth hormone secretion 57 pharmacologic intervention 57 diarrhea predominant irritable 57 renal disease 57 myasthenia gravis MG 57 mitochondrial dysfunction 57 insulin sensitizers 57 nerve degeneration 57 immune modulator 57 renal fibrosis 57 mitochondrial toxicity 57 Critical limb ischemia 57 Symadex 57 Psoriatic arthritis 57 induce apoptosis 57 myeloproliferative diseases 57 disease NAFLD 57 glitazones 57 intermittent claudication 57 sodium glucose cotransporter 56 COX2 56 progressive degenerative 56 T2DM 56 nonalcoholic steatohepatitis NASH 56 pharmacological chaperone 56 Factor VIIa 56 cardioprotection 56 JAK3 56 rheumatoid arthritis multiple sclerosis 56 Diabetes mellitus 56 essential thrombocythemia 56 Insulin resistance 56 erythropoietic 56 endotoxemia 56 secondary hyperparathyroidism 56 myopathies 56 insulin sensitizing 56 HIV lipodystrophy 56 diabetes dyslipidemia 56 PPAR gamma agonists 56 Vitamin D insufficiency 56 systemic lupus erythematosus 56 multisystem disease 56 epithelial tumors 56 cystic fibrosis chronic pancreatitis 56 cardiometabolic disorders 56 neurocognitive deficits 56 Glucocorticoids 56 cardiovascular disease hypertension 56 antidiabetic 56 acromegaly 56 cognitive dysfunction 56 diabetic gastroparesis 56 neurodegenerative 56 hypercalcaemia 56 selective inhibition 56 arterial calcification 56 vasodilatation 56 CTAP# Capsules 56 ThGRF 56 Squalamine 56 fibrosis 56 galanin 56 MELAS syndrome 56 monoclonal gammopathy 56 T1DM 56 schizophrenia CIAS 56 vaso occlusive crisis 56 cannabinoid receptors 56 fibromyalgia syndrome 56 apoptotic pathway 56 paraneoplastic 56 neurodegenerative disease 56 neuroinflammation 56 systemic amyloidosis 56 AT1R 56 hematologic disorders 56 nonmelanoma skin cancers 56 Interferon beta 56 disease progression 56 lactic acidosis 56 DFMO 56 pramlintide 56 davalintide 56 GRNCM1 56 ADAMTS# 56 Severe Primary IGFD 56 miR #a [001] 56 leukemia AML 56 NF2 56 progressive degeneration 56 Wet AMD 56 familial adenomatous polyposis 56 selective modulator 56 Diabetic neuropathy 56 progressive neurodegenerative disease 56 Cushing Syndrome 56 endometrial hyperplasia 55 immunomodulatory 55 pathophysiologic 55 CB2 receptor 55 myelofibrosis polycythemia vera 55 atherosclerosis 55 fatal neurodegenerative disorder 55 IL 1ß 55 receptor agonists 55 deferiprone 55 TTR amyloidosis 55 NYHA Class II 55 CYT# potent vascular disrupting 55 PTP 1B 55 AAT Deficiency 55 Magnesium deficiency 55 selective androgen receptor modulator 55 metabolic acidosis 55 proinflammatory cytokines 55 Fibrosis 55 sporadic ALS 55 choroidal neovascularization 55 Mucositis 55 Cognitive impairment 55 metastatic gastric 55 metastatic bone 55 RNAi therapeutic targeting 55 systolic hypertension 55 hypophosphatasia 55 antiproliferative effects 55 Pulmonary arterial hypertension 55 G6PD deficiency 55 angiogenesis inhibition 55 retinitis pigmentosa RP 55 axonal degeneration 55 Metastatic breast cancer 55 liver scarring 55 vWD 55 cardiotoxicity 55 #beta HSD1 55 homozygous familial hypercholesterolemia 55 pulmonary arterial hypertension PAH 55 neurotrophic 55 neuro degenerative diseases 55 post transplant lymphoproliferative 55 clazosentan 55 benign prostatic hypertrophy BPH 55 Myelofibrosis 55 Myelodysplastic Syndrome MDS 55 vascular inflammation 55 diabetes mellitus T2DM 55 immunomodulatory agents 55 androgen receptor AR 55 Tasimelteon 55 Chronic pancreatitis 55 AAT deficiency 55 hepatocellular carcinoma 55 hyperglycaemia 55 Friedreich Ataxia FRDA 55 underlying pathophysiology 55 neuropsychiatric disorders 55 pancreatic insufficiency 55 SGS# 55 neovascular 55 hypoparathyroidism 55 Safinamide 55 hypovitaminosis D 55 adrenal insufficiency 55 diabetic neuropathic pain 55 ceroid lipofuscinosis NCL 55 hyperparathyroidism 55 hyperoxaluria 55 ATTR PN 55 eosinophilic asthma 55 JAK2 enzyme 55 muscle wasting 55 arterial hypertension 55 hyperprolactinemia 55 inflammatory arthritis 55 partial agonist 55 macrovascular complications 55 Rheumatoid Arthritis RA 55 ACV1 55 ostarine 55 idiopathic pulmonary fibrosis IPF 55 osteoarthritis rheumatoid arthritis 55 alcoholic fatty liver 55 pyridostigmine 55 chronic periodontitis 55 degenerative neurological condition 55 Morquio 55 skeletal metastases 55 NMDA receptor antagonists 55 endocrine diseases 55 Peripheral neuropathy 55 metabolic disorders 55 VEGF receptor 55 plasma kallikrein 55 TRIOLEX 55 mitochondrial decay 55 torsade de pointes 55 TNF antagonist 55 inverse agonist 55 cardiac fibrosis 55 Fibrillex TM 55 agomelatine 55 thrombocytosis 55 excitotoxic 54 SCD1 54 neurodegenerative diseases 54 spinocerebellar ataxia 54 OHR/AVR# 54 6R BH4 54 steatohepatitis 54 lysosomal storage disease 54 Diabetic Macular Edema 54 Fabry Disease 54 lipid abnormalities 54 TRO# 54 Maroteaux Lamy syndrome 54 kidney insufficiency 54 inflammatory demyelinating 54 myeloproliferative neoplasms 54 TNF Tumor Necrosis Factor 54 nephropathy 54 opioid induced constipation 54 vWF 54 MPS VI 54 debilitating complication 54 familial amyloidotic polyneuropathy FAP 54 systemic inflammation 54 carcinoid syndrome 54 multiple myeloma MM 54 Aviptadil 54 Ischemic 54 Miraxion 54 monogenic 54 Hepatocellular Carcinoma HCC 54 proliferative diabetic retinopathy 54 nNOS 54 RANK Ligand 54 Leber Hereditary Optic Neuropathy 54 androgenic alopecia 54 cytopenia 54 PSN# [002] 54 rufinamide 54 terlipressin 54 tramiprosate 54 proteasome inhibitors 54 oxypurinol 54 pathophysiological effects 54 inherited neurodegenerative 54 kallikrein 54 idiopathic myelofibrosis 54 fatty acid oxidation 54 neuropsychiatric diseases 54 engineered RAP peptides 54 dyslipidemia 54 hyperinsulinemia 54 cardiovascular morbidity 54 fibrotic disorders 54 hereditary degenerative 54 sortilin 54 ABCB1 54 lung fibrosis 54 NAFLD 54 aldosterone hormone 54 thyroid dysfunction 54 neuro degenerative disease 54 hypercholesterolemia 54 motor neuron diseases 54 TRAIL induced apoptosis 54 treating neuropathic pain 54 Alzheimers disease 54 prostate carcinogenesis 54 cartilage degeneration 54 lysosomal 54 PTHrP 54 ADPKD 54 Fabry disease 54 Cushing syndrome 54 nephrotoxicity 54 RhuDex ® 54 riociguat 54 signaling cascades 54 rare autosomal recessive 54 ERK signaling 54 neovascularisation 54 EGFr 54 protein misfolding 54 HGPS 54 chronic neuropathic pain 54 TGF β 54 LPS induced 54 hyperphosphatemia 54 myelofibrosis 54 NAGS deficiency 54 receptor tyrosine kinase inhibitor 54 HbF 54 aMCI precursor 54 acute mania 54 cardio renal 54 lipohypertrophy 54 neurologic diseases 54 Torisel 54 lomitapide 54 diabetic complications 54 opioid induced bowel dysfunction 54 erythematosus 54 vidofludimus 54 familial hypercholesterolemia 54 Bronchiectasis 54 leukotriene pathway 54 neurogenic 54 metastatic RCC 54 OXIGON TM 54 heterozygous FH 54 Autoimmune diseases 54 Acidosis 54 microvascular complications 54 hepatic encephalopathy 54 Fatty liver 54 MPS IVA 54 immunomodulatory effects 54 activate AMPK 54 Peripheral artery disease 54 Vidaza azacitidine 54 osteosarcomas 54 Diabetic nephropathy 54 diabetic neuropathy 54 LRRK2 mutations 54 herpes zoster shingles 54 RhuDex 54 Androgen 54 liver metastasis 54 p# inhibitor 54 cerebral vasospasm 54 neuroinflammatory 54 late infantile neuronal 54 mitochondrial disorders 54 hemoglobinopathies 54 #ME# 54 squamous cell lung cancer 54 beta interferon 54 Testosterone deficiency 54 romazarit 54 androgenetic alopecia 54 physiologic mechanisms 54 CP CPPS 54 tolvaptan 54 pharmacological therapies 54 blood clotting disorder 54 gastrointestinal dysfunction 54 alpha interferons 54 TGF b 54 osteopontin 54 generalized seizures 54 Fas ligand 54 Janus kinase 54 prognostic marker 54 Hyperthyroidism 54 antioxidant supplementation 54 inhibitory neurotransmitters 54 glucocorticoid therapy 54 IL 1β 54 epilepsies 54 hypercalcemia 54 neurological syndromes 54 neuronal nitric oxide synthase 54 neuroprotective properties 54 uricase 54 bexarotene 54 hereditary antithrombin deficiency 54 peroxisome proliferator activated 54 atherogenic dyslipidemia 54 chemotherapy induced neutropenia 54 androgen deprivation 54 Dilated cardiomyopathy 54 dysregulated 54 androgen deficiency 54 elevated uric acid 54 PKC beta 54 hyperuricemia 53 gastric carcinogenesis 53 Fc fusion protein 53 Leber Congenital Amaurosis LCA 53 systemic scleroderma 53 thetreatment 53 INS# [001] 53 myeloproliferative 53 secretory diarrhea 53 Aß 53 Peripheral Artery Disease 53 neurodegeneration 53 chronic hepatitis cirrhosis 53 mutant huntingtin protein 53 mGluR5 antagonist 53 activin 53 neuroprotective effects 53 HIF 1α 53 Parnate 53 statins cholesterol lowering 53 pathogenetic 53 erlotinib Tarceva 53 amyotrophic lateral sclerosis ALS 53 PDGFR 53 deacetylase inhibitors 53 HER2 overexpression 53 gastrointestinal mucositis 53 eprotirome 53 GW# [003] 53 neuronal cell 53 skeletal muscle mass 53 Hashimoto thyroiditis 53 antiapoptotic 53 cytoprotective 53 opioid induced 53 medullary thyroid cancer 53 neurologic symptoms 53 Duchenne Muscular Dystrophy DMD 53 Systemic lupus erythematosus SLE 53 Mipomersen 53 neovascularization 53 Iron deficiency anemia 53 neuroendocrine tumors 53 disease modifying 53 neurotrophic factor 53 UCP2 53 CRVO 53 gastrointestinal motility 53 P#X# 53 Female Sexual Arousal 53 leptin resistance 53 pediatric malignancies 53 Abeta# 53 Pompe Disease 53 familial hypercholesterolemia FH 53 Chronic lymphocytic leukemia 53 lysosomal storage disorder 53 CB1 receptor 53 RNAi therapeutic targeting PCSK9 53 oral RSD# 53 chemopreventive agent 53 renin angiotensin system 53 STRIDE PD 53 receptor subtype 53 psoriasis psoriatic arthritis 53 immune modulation 53 panitumumab Vectibix 53 HBeAg negative 53 Parkinsons disease 53 rheumatic diseases 53 complement inhibitor eculizumab 53 autonomic dysfunction 53 allergic inflammation 53 immuno inflammatory diseases 53 levodopa therapy 53 MTP inhibitor 53 myocardial fibrosis 53 Idiopathic pulmonary fibrosis 53 activated microglia 53 hippocampal atrophy 53 PPARγ 53 γ secretase 53 Bicifadine 53 Papillary 53 EVIZON TM 53 Dysregulation 53 ATACAND 53 metabolic disturbances 53 renal flares 53 protein tyrosine phosphatase 1B 53 chorea associated 53 aromatase inhibitors AIs 53 systemic autoimmune 53 tafamidis 53 rheumatoid arthritis Crohn disease 53 oral antidiabetic drugs 53 diabetic microvascular complications 53 atherosclerotic disease 53 JAK inhibitors 53 microvascular disease 53 limb ischemia 53 myopathy 53 frataxin 53 Alzheimer disease cognitive impairment 53 ALN TTR 53 diabetic macular edema 53 hypertension hypercholesterolemia 53 herpes labialis 53 FLT3 53 extrapyramidal symptoms 53 oxysterols 53 Major Depressive Disorder 53 variceal bleeding 53 thromboembolic disease 53 receptor antagonist 53 mediated apoptosis 53 HIV HCV coinfected 53 LHON 53 Overactive bladder 53 acadesine 53 skeletal muscle weakness 53 catabolic 53 FTLD 53 alpha synuclein protein 53 pharmacological treatments 53 VaD 53 excitotoxicity 53 idiopathic thrombocytopenic purpura ITP 53 cardiovascular hospitalization 53 antitumor effects 53 exocrine pancreatic insufficiency 53 immune mediated 53 constipation predominant irritable bowel 53 carcinoid tumors 53 hematopoietic cancers 53 mGluR4 activation 53 Interferon Beta 53 JAK2 inhibitor 53 glucose homeostasis 53 chronic renal disease 53 Tolvaptan 53 amyloid pathology 53 mTOR inhibitors 53 anorexia cachexia 53 CIPN 53 ISIS # 53 axonal damage 53 rheumatoid arthritis osteoarthritis ankylosing 53 refractory angina 53 EGFR inhibitors 53 uPA 53 HuLuc# 53 adenosine A2A 53 impaired glucose metabolism 53 muscle degeneration 53 Avanafil 53 fluid overload 53 systemic lupus erythematosus SLE 53 adrenal suppression 53 neuroprotective 53 CYP #A# 53 inappropriate antidiuretic hormone SIADH 53 Vascular Endothelial Growth 53 vitamin D insufficiency 53 Pseudomonas aeruginosa infections 53 Ribavirin causes 53 molecular abnormalities 53 TNF inhibitors 53 Microplasmin 53 Cetrorelix 53 PD LID 53 Myasthenia gravis 53 antibody mediated 53 anti amnesic 53 Zavesca 53 Rasagiline 53 Alzheimers Disease 53 angiotensin receptor blockers 53 Darapladib 53 Torsades de Pointes 53 prognostic indicator 53 HIV associated lipodystrophy 53 dopaminergic neurons 53 smoldering myeloma 53 progranulin mutations 53 CEACAM1 53 Non Alcoholic Fatty 53 Bisphosphonate 53 mitochondrial respiration 53 antiplatelet therapies 53 CTEPH 53 peripheral neuropathy CIPN 53 Rhabdomyolysis 53 sudden sensorineural hearing 53 visilizumab 53 RANKL 53 hormone refractory 53 cholinergic tone 53 nephropathic cystinosis 53 dopaminergic 53 inflammatory autoimmune diseases 53 pathogenic mechanisms 53 co morbidities 53 severe oral mucositis 53 GnRH agonists 53 interstitial cystitis 53 Cockayne Syndrome 53 Gastroparesis 53 Bulimia Nervosa 53 vasospasm 53 bone metastases 53 Genetic variants 53 diabetes mellitus DM 53 retinal vein occlusion 53 hepatorenal syndrome 53 paroxysmal nocturnal hemoglobinuria 53 psoriasis rheumatoid arthritis 53 inflammatory bowel diseases 53 TÎ ² 4 53 prediabetic 53 Serdaxin 53 delta isoform 53 spongiform encephalopathies 53 cholinesterase inhibitors 53 Enkephalin 53 hypertriglyceridemia 53 autoimmune thyroid 53 pulmonary hypertension PH 53 antihypertensive therapy 53 leukoencephalopathy 53 ALN TTR# 53 telomere dysfunction 53 NSAID induced 53 retinal degeneration 53 amyloid peptide 53 parkinsonian symptoms 53 neurodegenerative disorders 53 chronic degenerative 53 euthymic patients 53 panobinostat 53 constipation OIC 53 Raynaud syndrome 53 cerebral ischemia 53 proliferative diseases 53 post thrombotic syndrome 53 chronic relapsing 53 ropinirole Requip 53 darapladib 53 Triolex 53 neuroendocrine cancers 53 muscarinic receptors 53 acetylcholine receptor 53 SIADH 53 LPA1 53 Prodarsan R 53 cannabinor 53 c MET 53 remyelination 53 fatty acid synthase 53 Xyfid TM 53 acetonide FA 53 airway remodeling 53 polyneuropathy HIV DSP 53 COX enzymes 53 benign prostatic hyperplasia 53 macrovascular events 53 iron overload 53 autoantibody 53 anemias 53 serum triglycerides 53 refractory gout 53 delayed CINV 53 Thiazolidinediones 53 Colorectal cancers 53 Parkinson disease Alzheimer disease 53 claudication 53 Akt activation 53 SYN# 52 nalbuphine ER 52 Leydig cell 52 hematologic diseases 52 neurological manifestations 52 dexpramipexole 52 Prodarsan ® 52 pouchitis 52 Myelodysplastic syndromes MDS 52 TMEM#B 52 insulin sensitizer 52 overactive bladder symptoms 52 haematologic 52 amenorrhea 52 NMDA receptor antagonist 52 Anavex #-# 52 PI3K/mTOR 52 vitreoretinal disorders 52 idiopathic Parkinson disease 52 hormone ablation 52 Carcinoid tumors 52 pheochromocytoma 52 L dopa 52 ADAM# 52 neuropathologic 52 metastatic malignant melanoma 52 metastatic disease 52 post menopausal osteoporosis 52 hyperammonemia 52 prostate cancer CaP 52 telomere shortening 52 resistin 52 chronic myocardial ischemia 52 bowel dysfunction 52 Bevacizumab 52 5 HT6 receptor 52 Sezary syndrome 52 non metastatic osteosarcoma 52 dyslipidaemia 52 orally administered inhibitor 52 coronary vasodilation 52 dexanabinol 52 Panzem R 52 haloperidol Haldol 52 acetylcholinesterase inhibitors 52 chemoresistant 52 pathological hallmark 52 geographic atrophy 52 interferon gamma 1b 52 Vitamin B# deficiency 52 tonic clonic seizures 52 Hemophilia B 52 MS relapses 52 T#I [002] 52 transthyretin TTR mediated amyloidosis 52 systemic lupus erythematosus psoriasis 52 prokinetic agent 52 pancreatic adenocarcinoma 52 ACh 52 Sudhir Agrawal D.Phil 52 TELINTRA 52 bone resorption 52 histone deacetylase 52 chronic musculoskeletal 52 1 diabetes T1D 52 LHRH antagonists 52 tocilizumab 52 imatinib Gleevec ® 52 SOD1 52 myeloproliferative disorders 52 NOMID 52 fibrotic diseases 52 Irritable Bowel Syndrome IBS 52 acetylcholinesterase AChE 52 decompensated cirrhosis 52 Benign Prostatic Hyperplasia 52 Pimavanserin 52 NMDA antagonist 52 Lu AA# 52 knee osteoarthritis OA 52 insulin secreting cells 52 5 HT4 receptor 52 tauopathies 52 relapsed ALL 52 carbohydrate metabolism 52 prostanoid 52 PPAR γ 52 antiangiogenic 52 homozygous FH 52 arthritis RA 52 eNOS 52 SNT-MC#/idebenone 52 DGAT1 52 primary Restless Legs 52 IRX 2 52 NF1 52 PDGF receptor 52 mu opioid receptor antagonist 52 Cogane 52 thromboxane A2 52 SSc 52 pharmacological interventions 52 recurrent glioblastoma multiforme 52 INCB# [003] 52 MTHFR 52 post operative ileus 52 Nexavar sorafenib 52 Bulimia nervosa 52 Ceflatonin 52 phosphate S1P 52 ZFP Therapeutic 52 Angioedema 52 Gaucher Disease 52 neurological degeneration 52 nicotinic receptor 52 myoclonus 52 estrogen deficiency 52 Neurodegenerative diseases 52 Hutchinson Gilford progeria 52 SERMs 52 gefitinib Iressa 52 neurodegenerative disorder characterized 52 inherited neurological disorder 52 small molecule thrombopoietin 52 coagulation cascade 52 Acute Renal Failure 52 lupus multiple sclerosis 52 hypothyroidism 52 Hypothyroidism 52 Haptoglobin 52 autosomal recessive disorder 52 anticancer treatments 52 leptin receptor 52 immuno modulatory 52 fatal neurodegenerative 52 IAP inhibitor 52 Alemtuzumab 52 olmesartan 52 VA# [002] 52 Cutaneous T 52 Topiramate 52 LPA1 receptor 52 postmenopausal estrogen 52 hematological malignancy 52 Granulocyte Colony Stimulating Factor 52 Factor VEGF 52 5 HT2A receptor 52 transgenic mouse models 52 gastrin 52 nicotinic receptors 52 CGEN # 52 adiponectin 52 isotypes 52 post herpetic neuralgia PHN 52 BH4 52 hormone gastrin 52 Major Depressive Disorder MDD 52 tumor necrosis 52 K ras mutations 52 Parkinsonian 52 neuroprotection 52 Decitabine 52 neuronal degeneration 52 small molecule activators 52 juvenile idiopathic arthritis 52 uncontrolled seizures 52 therapeutic modality 52 DITPA 52 acute leukemias 52 clioquinol 52 extrapyramidal symptoms EPS 52 SNT MC# 52 fibrin deposition 52 sJIA 52 immunodeficiency disorders 52 IGFBP 3 52 antithrombotic therapy 52 nonsense mutation 52 Parkinsonian Syndromes 52 potassium sparing diuretics 52 neurologic disorder 52 sodium thiosulfate STS 52 beta interferons 52 hyperalgesia 52 opioid receptor antagonist 52 peritumoral brain edema 52 Hedgehog pathway 52 gastric carcinoma 52 Xanafide 52 myositis 52 PXD# 52 binge eating disorders 52 osteoclast activity 52 IGFBP2 52 anti CD3 antibody 52 Myotonic dystrophy 52 Hypercholesterolemia 52 Serostim ® 52 adalimumab Humira 52 apoptosis induced 52 pharmacologic treatments 52 Chronic myeloid leukemia 52 imatinib resistance 52 Clusterin 52 abdominal adiposity 52 Dyskinesia 52 renal kidney 52 Syncria R 52 Friedreich ataxia 52 diabetes hyperlipidemia 52 iNOS 52 generalized epilepsy 52 GBA mutations 52 myotonia 52 ventricular remodeling 52 anti fibrotic 52 targeted radiotherapeutic 52 metabolic syndromes 52 hepatocellular 52 acute GvHD 52 interstitial nephritis 52 familial ALS 52 platelet activation 52 capillary leak 52 MYCN amplification 52 Genetic predisposition 52 pathophysiological 52 granulomatous 52 venous thromboembolic events 52 xerostomia 52 adrenal function 52 neuron degeneration 52 lichen planus 52 renal insufficiency 52 Alzheimer pathology 52 nonalcoholic fatty liver 52 atherogenesis 52 Enbrel Humira 52 corticosteroid therapy 52 LRP1 52 atherothrombotic disease 52 hormonal abnormalities 52 gouty arthritis 52 CagA 52 Oxidative stress 52 TMS Therapy 52 Idiopathic Pulmonary Fibrosis IPF 52 PDE7 52 Smad3 52 Systemic Lupus Erythematosus 52 delayed gastric emptying 52 NTDDS 52 ischemia induced 52 hepatotoxicity 52 Akt 52 mycosis fungoides 52 neovascular AMD 52 E#F# 52 ophthalmic diseases 52 trastuzumab Herceptin ® 52 cirrhosis liver cancer 52 Exelixis XL# 52 testicular tumors 52 pro angiogenic 52 metastatic colorectal 52 neuropsychiatric symptoms 52 Cognitive Deficits 52 Venous thromboembolism 52 Abeta peptide 52 cardiac toxicity 52 CORT # 52 myotonic dystrophy 52 mTOR mammalian target 52 Thrombocytopenia 52 Crohn disease CD 52 RSV infections 52 serotonin receptor 52 Tyrima 52 ACZ# 52 aberrantly activated